{
    "clinical_study": {
        "@rank": "16655", 
        "acronym": "RESILIENT", 
        "arm_group": [
            {
                "arm_group_label": "BYM338/bimagrumab High Dose", 
                "arm_group_type": "Experimental", 
                "description": "60 patients who meet all inclusion criteria and none of the exclusion criteria will be treated with the BYM338 High Dose administered via intravenous infusion from Day 1 to Week 52, and up to Week 104."
            }, 
            {
                "arm_group_label": "BYM338/bimagrumab Mid Dose", 
                "arm_group_type": "Experimental", 
                "description": "60 patients who meet all inclusion criteria and none of the exclusion criteria will be treated with the BYM338 Mid Dose administered via intravenous infusion from Day 1 to Week 52, and up to Week 104."
            }, 
            {
                "arm_group_label": "BYM338/bimagrumab Low Dose", 
                "arm_group_type": "Experimental", 
                "description": "60 patients who meet all inclusion criteria and none of the exclusion criteria will be treated with the BYM338 Low Dose administered via intravenous infusion from Day 1 to Week 52, and up to Week 104."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "60 patients who meet all inclusion criteria and none of the exclusion criteria will be receive matching placebo administered via intravenous infusion from Day 1 to Week 52, and up to Week 104."
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the efficacy, safety and tolerability of multiple doses of bimagrumab/BYM338 vs\n      placebo, when administered intravenously (i.v.), on physical function, muscle strength, and\n      mobility in patients with sporadic inclusion body myositis (sIBM)"
        }, 
        "brief_title": "Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Sporadic Inclusion Body Myositis", 
        "condition_browse": {
            "mesh_term": [
                "Myositis", 
                "Myositis, Inclusion Body"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Diagnosed with sporadic inclusion body myositis; Must be able to walk (assistive aids\n        allowed, including intermittent use of wheelchair);\n\n        Exclusion Criteria:\n\n        Must not have other conditions that significantly limit ability to move around; Must not\n        be using corticosteroids. Must not have used systemic corticosteroid (at daily dose >=10mg\n        prednisone) for the past 3 months; Must meet cardiovascular requirements; Must not be\n        pregnant or nursing; Must not have a chronic active infection (e.g., HIV, hepatitis B or\n        C, tuberculosis, etc); Other protocol-defined inclusion/exclusion criteria may apply"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "36 Years"
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01925209", 
            "org_study_id": "CBYM338B2203"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "BYM338/bimagrumab High Dose", 
                    "BYM338/bimagrumab Mid Dose", 
                    "BYM338/bimagrumab Low Dose"
                ], 
                "description": "BYM338 will be administered via intravenous infusion to randomized patients beginning on Day 1 through Week 52, and up to Week 104.", 
                "intervention_name": "BYM338/bimagrumab", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Matching placebo will be administered via intravenous infusion to 60 randomized patients beginning on Day 1 through Week 52, and up to Week 104.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "sporadic inclusion body myositis,", 
            "myositis,", 
            "muscle wasting,", 
            "controlled clinical trial,", 
            "randomized,", 
            "body mass,", 
            "muscle function,", 
            "strength,", 
            "performance,", 
            "physical function"
        ], 
        "lastchanged_date": "March 21, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Neuromuscular Research Center, Contact: K. Sivakumar", 
                    "phone": "888-669-6682"
                }, 
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85028"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "University of California, Irvine Contact: N. Goyal", 
                    "phone": "888-669-6682"
                }, 
                "facility": {
                    "address": {
                        "city": "Orange", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92868"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "University of California, Davis Contact: B. Oskarsson", 
                    "phone": "888-669-6682"
                }, 
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95817"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "University of Miami Contact: D. Ascherman", 
                    "phone": "888-669-6682"
                }, 
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33101"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "University of Kansas Medical Center Contact: R. Barohn", 
                    "phone": "888-669-6682"
                }, 
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "66160"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Johns Hopkins University Contact: T. Lloyd", 
                    "phone": "888-669-6682"
                }, 
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21287"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Colubus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43221"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Oregon Health and Science University Contact: T. Marburger", 
                    "phone": "888-669-6682"
                }, 
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97239"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75235"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Nerve & Muscle Center of Texas Contact: A. Shaibani", 
                    "phone": "888-669-6682"
                }, 
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Leonards", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2065"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cauldfield", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3162"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nedlands", 
                        "country": "Australia", 
                        "state": "Western Australia", 
                        "zip": "6009"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bruxelles", 
                        "country": "Belgium", 
                        "zip": "1200"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium", 
                        "zip": "2650"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gent", 
                        "country": "Belgium", 
                        "zip": "9000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark", 
                        "zip": "2100"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75013"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brescia", 
                        "country": "Italy", 
                        "state": "BS", 
                        "zip": "25123"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Messina", 
                        "country": "Italy", 
                        "state": "ME", 
                        "zip": "98125"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20133"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Padova", 
                        "country": "Italy", 
                        "state": "PD", 
                        "zip": "35128"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pavia", 
                        "country": "Italy", 
                        "state": "PV", 
                        "zip": "27100"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "state": "RM", 
                        "zip": "00168"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nagoya-city", 
                        "country": "Japan", 
                        "state": "Aichi", 
                        "zip": "466-8560"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kumamoto City", 
                        "country": "Japan", 
                        "state": "Kumamoto", 
                        "zip": "860-8556"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sendai-city", 
                        "country": "Japan", 
                        "state": "Miyagi", 
                        "zip": "980-8574"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Osaka-city", 
                        "country": "Japan", 
                        "state": "Osaka", 
                        "zip": "534-0021"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tokushima-city", 
                        "country": "Japan", 
                        "state": "Tokushima", 
                        "zip": "770-8503"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kodaira-city", 
                        "country": "Japan", 
                        "state": "Tokyo", 
                        "zip": "187-8551"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wakayama-city", 
                        "country": "Japan", 
                        "state": "Wakayama", 
                        "zip": "641-8510"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leiden 2333 ZA", 
                        "country": "Netherlands", 
                        "zip": "2333"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warszawa", 
                        "country": "Poland", 
                        "zip": "02-097"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zuerich", 
                        "country": "Switzerland", 
                        "zip": "8091"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia", 
                "Belgium", 
                "Denmark", 
                "France", 
                "Italy", 
                "Japan", 
                "Netherlands", 
                "Poland", 
                "Switzerland"
            ]
        }, 
        "number_of_arms": "4", 
        "official_title": "Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate Efficacy, Safety, Tolerability of i.v. BYM338 at 52 Weeks on Physical Function, Muscle Strength, and Mobility in Sporadic Inclusion Body Myositis Patients", 
        "overall_contact": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone": "1-888-669-6682"
        }, 
        "overall_contact_backup": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone_ext": "+41613241111"
        }, 
        "overall_official": {
            "affiliation": "Novartis Pharmaceuticals", 
            "last_name": "Novartis Pharmaceuticals", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Australia: Department of Health and Ageing Therapeutic Goods Administration", 
                "Belgium: Federal Agency for Medicinal Products and Health Products", 
                "Denmark: Danish Medicines Agency", 
                "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
                "Germany: Paul-Ehrlich-Institut", 
                "Italy: Ethics Committee", 
                "Italy: National Monitoring Centre for Clinical Trials - Ministry of Health", 
                "Japan: Pharmaceuticals and Medical Devices Agency", 
                "Netherlands: Medicines Evaluation Board (MEB)", 
                "Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products", 
                "Switzerland: Swissmedic", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change from baseline to Week 52 in the distance a patient can walk in a set timeframe. 6 Minute Walking Distance Test measures the distance (in meters) that a patient can walk in a 6 minute timeframe.", 
            "measure": "Change from Baseline in 6 Minute Walking Distance Test (6MWD) meters to Week 52", 
            "safety_issue": "No", 
            "time_frame": "Baseline, Week 52"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01925209"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Change from baseline to Week 52 in the total and appendicular lean body mass", 
                "measure": "Change from Baseline in lean body mass (LBM) at Week 52", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 52"
            }, 
            {
                "description": "Change from baseline to Week 52 in quadriceps QMT.", 
                "measure": "Change from Baseline in quadriceps Quantitative Muscle Testing (QMT) at Week 52", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 52"
            }, 
            {
                "description": "Change from baseline to Week 52 in a patient reported outcome instrument.", 
                "measure": "Change from Baseline in Patient-Reported Physical Function at Week 52", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 52"
            }, 
            {
                "description": "Number of falls", 
                "measure": "Rate of Fall Events", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, Day 1, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, 84, 88, 92, 96, 100, 104, 108"
            }, 
            {
                "description": "Change from baseline to Week 52 in physical performance as measured by the Short Physical Performance Battery (SPPB).", 
                "measure": "Change from Baseline in Short Physical Performance Battery score at Week 52", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 52"
            }, 
            {
                "description": "Safety and tolerability", 
                "measure": "Safety and Tolerability of different i.v. BYM338 doses", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, Day 1, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, 84, 88, 92, 96, 100, 104, 108"
            }, 
            {
                "description": "Dose-response relationship", 
                "measure": "Change from Baseline in 6MWD meters to Week 52", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Week 52"
            }
        ], 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}